Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc.DLB · filed Dec 18, 2024
- Accession no.
- 0000950170-24-138158
- Filed
- Dec 18, 2024
- Trade date
- Dec 16-17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $963.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, Gen. Counsel & Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Class A Common Stock | AGrant or awardAcquired | +20,085 | $0.00 | $0 | 78,410 | Direct | |
| Dec 16, 2024 | Class A Common Stock | MOption exerciseAcquired | +5,192 | $0.00F3 | $0 | 83,602 | Direct | |
| Dec 16, 2024 | Class A Common Stock | FTax withholdingDisposed | −8,867 | $79.18 | −$702,089.06 | 74,735 | Direct | |
| Dec 17, 2024 | Class A Common Stock | SSaleDisposed | −4,625 | $77.83F6 | −$359,963.75 | 70,110 | Direct | |
| Dec 17, 2024 | Class A Common Stock | SSaleDisposed | −7,713 | $78.22F7 | −$603,310.86 | 62,397 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Class A Common Stock | AGrant or awardAcquired | +10,042 | $0.00 | $0 | 10,042 | Direct | |
| Dec 16, 2024 | Class A Common Stock | AGrant or awardAcquired | +35,307 | $0.00 | $0 | 35,307 | Direct | |
| Dec 16, 2024 | Class A Common Stock | MOption exerciseDisposed | −5,192 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock.
Referenced by the price of 1 transaction in Table I.
- F6
The shares were sold in multiple transactions at prices ranging from $77.02 to $78.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F7
The shares were sold in multiple transactions at prices ranging from $78.06 to $78.52, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.